SCHEMBL24937774

SCHEMBL24937774

O=C(N1CCN(c2ccc(Cl)cc2)CC1)n1ccnn1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 7/20 0.60
LMNA P02545 4/20 0.60
ALDH1A1 P00352 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
HPGD P15428 1/20 0.60
HTT P42858 1/20 0.60
TRPV1 Q8NER1 1/20 0.48
HSP90AA1 P07900 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
CHIA Q9BZP6 1/20 0.48
GRM5 P41594 1/20 0.46
NPC1 O15118 1/20 0.46
MAPT P10636 1/20 0.46
RAB9A P51151 1/20 0.46
ME2 P23368 1/20 0.46
ME1 P48163 1/20 0.46
ME3 Q16798 1/20 0.46
CA12 O43570 1/20 0.46
CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24937789 0.86 AKR1C3 (0.58) AKR1C3LMNAALDH1A1SMN1; SMN2HPGD
SCHEMBL24937848 0.82 AKR1C3 (0.61) AKR1C3SMN1; SMN2TRPV1MAPTME2
SCHEMBL24937728 0.82 KDM4E (0.47) AKR1C3
SCHEMBL24937187 0.82 AKR1C3 (0.60) AKR1C3GRM5
SCHEMBL24937862 0.81 AKR1C3 (0.62) AKR1C3LMNAALDH1A1SMN1; SMN2HTT
SCHEMBL24937761 0.79 AKR1C3 (0.58) AKR1C3LMNAALDH1A1SMN1; SMN2HTT
SCHEMBL24937183 0.78 AKR1C3 (0.65) AKR1C3LMNAALDH1A1SMN1; SMN2HPGD
SCHEMBL14276932 0.75 CASP6 (0.69) AKR1C3LMNAALDH1A1SMN1; SMN2HPGD
SCHEMBL5466673 0.74 AKR1C3 (0.73) AKR1C3LMNAALDH1A1SMN1; SMN2HPGD
SCHEMBL19078787 0.74 AKR1C3 (0.56) AKR1C3LMNAALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024778-A1 STRIGOLACTONE RECEPTOR INHIBITOR, AGRICULTURAL COMPOSITION AND USE THEREOF, STRIGA SEED GERMINATION INHIBITOR, AND TRIAZOLE UREA COMPOUND THE UNIVERSITY OF TOKYO (JP) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230024778-A1 STRIGOLACTONE RECEPTOR INHIBITOR, AGRICULTURAL COMPOSITION AND USE THEREOF, STRIGA SEED GERMINATION INHIBITOR, AND TRIAZOLE UREA COMPOUND UTS2R, TAS1R1, ULK3 AKR1C3 689/4885LMNA 4354/4885ALDH1A1 1950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.